Enlightenment Research’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,700
Closed -$447K 11
2022
Q3
$447K Buy
+6,700
New +$425K 0.99% 34
2019
Q1
Sell
-5,500
Closed -$245K 185
2018
Q4
$245K Buy
+5,500
New +$287K 0.3% 68

Other funds holding CAH

Enlightenment Research's CAH Position: Q4 2022 in Review

Enlightenment Research sold out of Cardinal Health (CAH) in Q4 2022, closing a stake of 6,700 shares — an estimated $447K sold.

Enlightenment Research first reported a position in CAH in Q4 2018 and held it in 2 quarters. The position peaked at $447K in Q3 2022. 931 funds tracked by Wall St. Rank hold CAH as of Q4 2022.

  • Enlightenment Research reported no remaining Cardinal Health position as of Q4 2022 after selling out during the quarter.
  • Enlightenment Research sold 6,700 Cardinal Health shares in Q4 2022, an estimated $447K.
  • Enlightenment Research first reported a position in Cardinal Health in Q4 2018 and held it in 2 quarters.
  • Enlightenment Research's Cardinal Health position peaked at $447K in Q3 2022.
  • 931 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2022.

Based on Enlightenment Research's 13F filing for Q4 2022.